Page 8 - Recent Operational News Today

10.08.2022 - -First Patient Treated in HOPE-3, the Pivotal Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy- -Positive One-Year Safety and Efficacy Results From HOPE-2 Open Label Extension Study of CAP-1002 in Non-Ambulant ...

Company Issues Shareholder Letter Vertical Aerospace Ltd. ("Vertical" or the "Company") (NYSE: EVTL; EVTLW), a global aerospace and technology company that is pioneering zero emission aviation, announces

Completed dose-escalation portion of the ongoing Phase 1 study of NTLA-2001 in patients with transthyretin amyloidosis with cardiomyopathy; expects to present interim safety and serum TTR reduction... | August 4, 2022

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Company Continues to Execute on its Long-Term Growth Strategy and its Transition to a Subscription-Based Business Model BEDFORD, Mass., July 26, 2022 -- Aware, Inc. , a leading...

Revenue Increased by 11% to $88.6 Million in Q3 FY22 compared to Q3 FY21 Increased Net Income by 9% to $15.5 million in Q3 FY22 compared to Q3 FY21 Gross Margin improved sequentially to 38.6% in Q3 FY22

/PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), one of Chinas leading internet and online game services providers,...

NetEase Reports First Quarter 2022 Unaudited Financial Results - NetEase, Inc. , one of Chinas leading internet and online game services providers, today announced its... | May 24, 2022

Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and CosmeticsInvestor